Back to Iowa

SF305 • 2026

A bill for an act relating to controlled substances, including certain controlled substances schedules and precursor substances reporting requirements, making penalties applicable, and including effective date provisions.(Formerly SSB 1080 .)

A bill for an act relating to controlled substances, including certain controlled substances schedules and precursor substances reporting requirements, making penalties applicable, and including effective date provisions.(Formerly SSB 1080 .)

Passed Legislature

This bill passed both chambers and reached final enrollment, even if later executive action is not shown here.

Sponsor
COMMITTEE ON HEALTH AND HUMAN SERVICES
Last action
2025-03-12
Official status
Withdrawn. S.J. 499 .
Effective date
Not listed

Plain English Breakdown

Using official source text because the generated explanation was unavailable or could not be confirmed against the official bill text.

A bill for an act relating to controlled substances, including certain controlled substances schedules and precursor substances reporting requirements, making penalties applicable, and including effective date provisions.(Formerly SSB 1080 .)

A bill for an act relating to controlled substances, including certain controlled substances schedules and precursor substances reporting requirements, making penalties applicable, and including effective date provisions.(Formerly SSB 1080 .)

What This Bill Does

  • A bill for an act relating to controlled substances, including certain controlled substances schedules and precursor substances reporting requirements, making penalties applicable, and including effective date provisions.(Formerly SSB 1080 .)

Limits and Unknowns

  • This entry is temporarily using official source text because the generated explanation could not be confirmed against the official bill text during the last sync.

Bill History

  1. 2025-03-12 Iowa Legislature

    Withdrawn. S.J. 499 .

  2. 2025-03-12 Iowa Legislature

    HF 182 substituted. S.J. 498 .

  3. 2025-02-24 Iowa Legislature

    Attached to HF 182 . S.J. 336 .

  4. 2025-02-13 Iowa Legislature

    Committee report, approving bill. S.J. 271 .

  5. 2025-02-13 Iowa Legislature

    Introduced, placed on calendar. S.J. 265 .

Official Summary Text

A bill for an act relating to controlled substances, including certain controlled substances schedules and precursor substances reporting requirements, making penalties applicable, and including effective date provisions.(Formerly SSB 1080 .)

Current Bill Text

Read the full stored bill text
Senate

File

305

-

Introduced

SENATE

FILE

305

BY

COMMITTEE

ON

HEALTH

AND

HUMAN

SERVICES

(SUCCESSOR

TO

SSB

1080)

A

BILL

FOR

An

Act

relating

to

controlled

substances,

including

certain

1

controlled

substances

schedules

and

precursor

substances

2

reporting

requirements,

making

penalties

applicable,

and

3

including

effective

date

provisions.

4

BE

IT

ENACTED

BY

THE

GENERAL

ASSEMBLY

OF

THE

STATE

OF

IOWA:

5

TLSB

1405SV

(1)

91

as/js

S.F.

305

Section

1.

Section

124.204,

subsection

2,

Code

2025,

is

1

amended

by

adding

the

following

new

paragraphs:

2

NEW

PARAGRAPH

.

cq.

2-methyl-N-(1-phenethylpiperidin-4-

3

yl)-N-phenylbutanamide.

Other

name:

alpha’-Methyl

butyryl

4

fentanyl.

5

NEW

PARAGRAPH

.

cr.

N-(1-(2,5-

6

dimethoxyphenethyl)piperidin-4-yl)-N-phenylpropionamide.

Other

7

name:

2’,5’-Dimethoxyfentanyl.

8

NEW

PARAGRAPH

.

cs.

N-(1-phenethylpiperidin-4-yl)-N-

9

phenylfuran-3-carboxamide.

Other

name:

3-Furanyl

fentanyl.

10

NEW

PARAGRAPH

.

ct.

3-methyl-N-(1-phenethylpiperidin-4-

11

yl)-N-phenylbutanamide.

Other

name:

Isovaleryl

fentanyl.

12

NEW

PARAGRAPH

.

cu.

N-(3-fluorophenyl)-N-(1-

13

phenethylpiperidin-4-yl)propionamide.

Other

name:

meta-

14

Fluorofentanyl.

15

NEW

PARAGRAPH

.

cv.

N-(3-fluorophenyl)-N-(1-

16

phenethylpiperidin-4-yl)isobutyramide.

Other

name:

meta-

17

Fluoroisobutyryl

fentanyl.

18

NEW

PARAGRAPH

.

cw.

N-(2-fluorophenyl)-N-(1-

19

phenethylpiperidin-4-yl)furan-2-carboxamide.

Other

name:

20

ortho-Fluorofuranyl

fentanyl.

21

NEW

PARAGRAPH

.

cx.

N-(4-methoxyphenyl)-N-(1-

22

phenethylpiperidin-4-yl)furan-2-carboxamide.

Other

name:

23

para-Methoxyfuranyl

fentanyl.

24

NEW

PARAGRAPH

.

cy.

N-(4-methylphenyl)-N-(1-

25

phenethylpiperidin-4-yl)cyclopropanecarboxamide.

Other

name:

26

para-Methylcyclopropyl

fentanyl.

27

NEW

PARAGRAPH

.

cz.

1-(2-methyl-4-(3-phenylprop-2-en-1-

28

yl)piperazin-1-yl)butan-1-one.

Other

name:

2-Methyl

AP-237.

29

NEW

PARAGRAPH

.

da.

2-(2-(4-ethoxybenzyl)-1H-

30

benzimidazol-1-yl)-N,N-diethylethan-1-amine.

Other

names:

31

etodesnitazene;

etazene.

32

NEW

PARAGRAPH

.

db.

2-(4-ethoxybenzyl)-5-nitro-1-(2-

33

(pyrrolidin-1-yl)ethyl)-1H-benzimidazole.

Other

names:

N-

34

pyrrolidino

etonitazene;

etonitazepyne.

35

-1-

LSB

1405SV

(1)

91

as/js

1/

6

S.F.

305

NEW

PARAGRAPH

.

dc.

N,N-diethyl-2-(5-nitro-2-(4-

1

propoxybenzyl)-1H-benzimidazol-1-yl)ethan-1-amine.

Other

name:

2

protonitazene.

3

Sec.

2.

Section

124.204,

subsection

4,

Code

2025,

is

amended

4

by

adding

the

following

new

paragraphs:

5

NEW

PARAGRAPH

.

cn.

N-(1-amino-3,3-dimethyl-1-

6

oxobutan-2-yl)-1-butyl-1H-indazole-3-carboxamide.

Other

name:

7

ADB-BUTINACA.

8

NEW

PARAGRAPH

.

co.

4-methyl-1-phenyl-2-(pyrrolidin-1-

9

yl)pentan-1-one.

Other

name:

alpha-PiHP.

10

NEW

PARAGRAPH

.

cp.

2-(methylamino)-1-(3-

11

methylphenyl)propan-1-one.

Other

names:

3-MMC;

3-

12

methylmethcathinone.

13

Sec.

3.

Section

124.204,

subsection

9,

Code

2025,

is

amended

14

by

adding

the

following

new

paragraphs:

15

NEW

PARAGRAPH

.

o.

Methyl

3,3-dimethyl-2-(1-(pent-4-en-

16

1-yl)-1H-indazole-3-carboxamido)butanoate.

Other

name:

17

MDMB-4en-PINACA.

18

NEW

PARAGRAPH

.

p.

Methyl

2-[[1-(4-fluorobutyl)indole-

19

3-carbonyl]amino]-3,3-dimethyl-butanoate.

Other

names:

20

4F-MDMB-BUTICA;

4F-MDMB-BICA.

21

NEW

PARAGRAPH

.

q.

N-(1-amino-3,3-dimethyl-1-oxobutan-

22

2-yl)-1-(pent-4-en-1-yl)-1H-indazole-3-carboxamide.

Other

23

name:

ADB-4en-PINACA.

24

NEW

PARAGRAPH

.

r.

5-Pentyl-2-(2-phenylpropan-2-

25

yl)pyrido[4,3-b]indol-1-one.

Other

names:

CUMYL-PEGACLONE;

26

SGT-151.

27

NEW

PARAGRAPH

.

s.

Ethyl

2-[[1-(5-fluoropentyl)indole-

28

3-carbonyl]amino]-3,3-dimethyl-butanoate.

Other

names:

29

5F-EDMB-PICA;

5F-EDMB-2201.

30

NEW

PARAGRAPH

.

t.

Methyl

2-(1-(4-fluorobenzyl)-1H-

31

indole-3-carboxamido)-3-methyl

butanoate.

Other

name:

MMB-

32

FUBICA.

33

NEW

PARAGRAPH

.

u.

N-ethyl-2-(2-(4-isopropoxybenzyl)-5-

34

nitro-1H-benzimidazol-1-yl)ethan-1-amine,

its

isomers,

esters,

35

-2-

LSB

1405SV

(1)

91

as/js

2/

6

S.F.

305

ethers,

salts,

and

salts

of

isomers,

esters,

and

ethers.

Other

1

name:

N-desethyl

isotonitazene.

2

NEW

PARAGRAPH

.

v.

2-(4-ethoxybenzyl)-5-nitro-1-(2-

3

piperidin-1-yl)-1H-benzimidazole,

its

isomers,

esters,

ethers,

4

salts,

and

salts

of

isomers,

esters,

and

ethers.

Other

names:

5

N-piperidinyl

etonitazene;

etonitazepipne.

6

Sec.

4.

Section

124.204,

subsection

9,

paragraphs

d,

h,

and

7

i,

Code

2025,

are

amended

by

striking

the

paragraphs.

8

Sec.

5.

Section

124.208,

subsection

6,

Code

2025,

is

amended

9

by

adding

the

following

new

paragraphs:

10

NEW

PARAGRAPH

.

bm.

5[alpha]-androstan-3,6,17-trione.

11

NEW

PARAGRAPH

.

bn.

6-bromo-androsta-1,4-diene-3,17-

12

dione.

13

NEW

PARAGRAPH

.

bo.

6-bromo-androstan-3,17-dione.

14

NEW

PARAGRAPH

.

bp.

4-chloro-17[alpha]-methyl-androsta-

15

1,4-diene-3,17[beta]-diol.

16

NEW

PARAGRAPH

.

bq.

4-chloro-17[alpha]-methyl-androst-

17

4-ene-3[beta],17[beta]-diol.

18

NEW

PARAGRAPH

.

br.

4-chloro-17[alpha]-methyl-17[beta]-

19

hydroxy-androst-4-en-3-one.

20

NEW

PARAGRAPH

.

bs.

4-chloro-17[alpha]-methyl-17[beta]-

21

hydroxy-androst-4-ene-3,11-dione.

22

NEW

PARAGRAPH

.

bt.

2[alpha],17[alpha]-dimethyl-

23

17[beta]-hydroxy-5[beta]-androstan-3-one.

24

NEW

PARAGRAPH

.

bu.

2[alpha],3[alpha]-epithio-

25

17[alpha]-methyl-5[alpha]-androstan-17[beta]-ol.

26

NEW

PARAGRAPH

.

bv.

estra-4,9,11-triene-3,17-dione.

27

NEW

PARAGRAPH

.

bw.

[3,2-c]furazan-5[alpha]-androstan-

28

17[beta]-ol.

29

NEW

PARAGRAPH

.

bx.

18a-homo-3-hydroxy-estra-2,5(10)-

30

dien-17-one.

31

NEW

PARAGRAPH

.

by.

4-hydroxy-androst-4-ene-3,17-dione.

32

NEW

PARAGRAPH

.

bz.

17[beta]-hydroxy-androstano[2,3-

33

d]isoxazole.

34

NEW

PARAGRAPH

.

ca.

17[beta]-hydroxy-androstano[3,2-

35

-3-

LSB

1405SV

(1)

91

as/js

3/

6

S.F.

305

c]isoxazole.

1

NEW

PARAGRAPH

.

cb.

3[beta]-hydroxy-estra-4,9,11-trien-

2

17-one.

3

NEW

PARAGRAPH

.

cc.

17[alpha]-methyl-androsta-1,4-

4

diene-3,17[beta]-diol.

5

NEW

PARAGRAPH

.

cd.

17[alpha]-methyl-5[alpha]-

6

androstan-17[beta]-ol.

7

NEW

PARAGRAPH

.

ce.

17[alpha]-methyl-androstan-3-

8

hydroxyimine-17[beta]-ol.

9

NEW

PARAGRAPH

.

cf.

6[alpha]-methyl-androst-4-ene-3,17-

10

dione.

11

NEW

PARAGRAPH

.

cg.

17[alpha]-methyl-androst-2-ene-

12

3,17[beta]-diol.

13

NEW

PARAGRAPH

.

ch.

[3,2-c]pyrazole-androst-4-en-

14

17[beta]-ol.

15

Sec.

6.

Section

124.208,

subsection

6,

paragraphs

a,

h,

v,

16

z,

aa,

am,

ay,

ba,

bb,

bc,

bk,

and

bl,

Code

2025,

are

amended

17

by

striking

the

paragraphs

and

inserting

in

lieu

thereof

the

18

following:

19

a.

3[beta],17[beta]-dihydroxy-5[alpha]-androstane.

20

h.

1-androstenedione

(5[alpha]-androst-1-en-3,17-dione).

21

v.

Furazabol

(17[alpha]-methyl-17[beta]-

22

hydroxyandrostano[2,3-c]furazan).

23

z.

Mestanolone

(17[alpha]-methyl-17[beta]-hydroxy-5[alpha]-

24

androstan-3-one).

25

aa.

Mesterolone

(1[alpha]-methyl-17[beta]-hydroxy-5[alpha]-

26

androstan-3-one).

27

am.

17[alpha]-methyl-[Delta]1-dihydrotestosterone

28

(17[beta]-hydroxy-17[alpha]-methyl-5[alpha]-androst-1-en-3-one)

29

(also

known

as

17-[alpha]-methyl-1-testosterone).

30

ay.

Oxandrolone

(17[alpha]-methyl-17[beta]-hydroxy-2-oxa-

31

5[alpha]-androstan-3-one).

32

ba.

Oxymetholone

(17[alpha]-methyl-2-hydroxymethylene-

33

17[beta]-hydroxy-5[alpha]-androstan-3-one).

34

bb.

Stanozolol

(17[alpha]-methyl-17[beta]-hydroxy-5[alpha]

35

-4-

LSB

1405SV

(1)

91

as/js

4/

6

S.F.

305

-androst-2-eno[3,2-c]-pyrazole).

1

bc.

Stenbolone

(17[beta]-hydroxy-2-methyl-5[alpha]-androst-

2

1-en-3-one).

3

bk.

Methasterone

(2[alpha],17[alpha]-dimethyl-5[alpha]

4

-androstan-17[beta]-ol-3-one

or

2[alpha],17[alpha]-dimethyl-

5

17[beta]-hydroxy-5[alpha]-androstan-3-one).

6

bl.

Prostanozol

(17[beta]-hydroxy-5[alpha]-androstano[3,2-

7

c]pyrazole

or

[3,2-c]pyrazole-5[alpha]-androstan-17[beta]-ol).

8

Sec.

7.

Section

124.210,

subsection

3,

Code

2025,

is

amended

9

by

adding

the

following

new

paragraph:

10

NEW

PARAGRAPH

.

bh.

Zuranolone.

11

Sec.

8.

Section

124B.2,

subsection

1,

paragraphs

y

and

ad,

12

Code

2025,

are

amended

to

read

as

follows:

13

y.

Iodine

in

concentrations

greater

than

2.2

percent

.

14

ad.

N-phenylpiperidin-4-amine(4-anilinopiperidine;

15

N-phenyl-4-piperidinamine;

4-AP),

its

amides,

its

carbamates,

16

and

its

halides,

its

salts

,

and

any

combination

thereof,

17

whenever

the

existence

of

such

is

possible

.

18

Sec.

9.

Section

124B.6,

Code

2025,

is

amended

by

adding

the

19

following

new

subsection:

20

NEW

SUBSECTION

.

5.

A

sale,

transfer,

furnishing,

or

21

receipt

of

a

chemical

mixture

identified

as

exempt

by

federal

22

regulation.

23

Sec.

10.

EFFECTIVE

DATE.

This

Act,

being

deemed

of

24

immediate

importance,

takes

effect

upon

enactment.

25

EXPLANATION

26

The

inclusion

of

this

explanation

does

not

constitute

agreement

with

27

the

explanation’s

substance

by

the

members

of

the

general

assembly.

28

This

bill

relates

to

controlled

substances,

including

29

certain

controlled

substances

schedules

and

precursor

30

substances

reporting

requirements.

31

The

bill

makes

changes

to

controlled

substances

schedules

32

I,

III,

and

IV

in

Iowa’s

uniform

controlled

substances

Act

33

(Code

chapter

124)

and

to

the

precursor

substances

reporting

34

requirement

in

Code

chapter

124B

to

conform

to

the

specific

35

-5-

LSB

1405SV

(1)

91

as/js

5/

6

S.F.

305

chemical

designations

of

the

substances

contained

in

Title

21

1

of

the

Code

of

Federal

Regulations,

parts

1300,

1308,

and

1310.

2

A

violation

involving

a

controlled

substance

included

in

the

3

bill

may

result

in

a

class

“B”

felony,

and

in

addition

to

the

4

25-year

mandatory

minimum

term

of

imprisonment

for

class

“B”

5

felons,

a

fine

of

not

less

than

$5,000

nor

more

than

$100,000;

6

a

class

“C”

felony

punishable

by

imprisonment

up

to

10

years

7

and

a

fine

of

not

less

than

$1,000

nor

more

than

$50,000;

or

an

8

aggravated

misdemeanor

punishable

by

imprisonment

up

to

2

years

9

and

a

fine

of

at

least

$855

but

not

more

than

$8,540.

10

The

bill

takes

effect

upon

enactment.

11

-6-

LSB

1405SV

(1)

91

as/js

6/

6